Publications

• Articles

  • Mickiewicz KM, Kawai Y, Drage L, Gomes MC, Davison F, Pickard R, Hall J, Mostowy S, Aldridge PD, Errington J. Possible role of L-form switching in recurrent urinary tract infection. Nature Communications 2019, 10(1), 4379.
  • Mickiewicz KM, Gays F, Lewis RJ, Brooks CG. Mutagenesis of Ly49B Reveals Key Structural Elements Required for Promiscuous Binding to MHC Class I Molecules and New Insights into the Molecular Evolution of Ly49s. Journal of Immunology 2014, 192(4), 1558-1569.
  • Aust JG, Gays F, Hussain F, Butcher GW, Kist R, Peters H, Brooks CG. Mice Lacking Ly49E Show Normal NK Cell Development and Provide Evidence for Probabilistic Expression of Ly49E in NK Cells and T Cells. Journal of Immunology 2011, 186(4), 2013-2023.
  • Gays F, Koh ASC, Mickiewicz KM, Aust JG, Brooks CG. Comprehensive analysis of transcript start sites in Ly49 genes reveals an unexpected relationship with gene function and a lack of upstream promoters. PLoS ONE 2011, 6(3), e18475.
  • Aust JG, Gays F, Mickiewicz KM, Buchanan E, Brooks CG. The Expression and Function of the NKRP1 Receptor Family in C57BL/6 Mice. Journal of Immunology 2009, 183(1), 106-116.
  • Gays F, Aust JG, Reid DM, Falconer J, Toyama-Sorimachi N, Taylor PR, Brooks CG. Ly49B is expressed on multiple subpopulations of myeloid cells. Journal of Immunology 2006, 177(9), 5840-5851.
  • Gays F, Martin K, Kenefeck R, Aust JG, Brooks CG. Multiple cytokines regulate the NK gene complex-encoded receptor repertoire of mature NK cells and T cells. Journal of Immunology 2005, 175(5), 2938-2947.
  • Toomey JA, Gays F, Foster D, Brooks CG. Cytokine requirements for the growth and development of mouse NK cells in vitro. Journal of Leukocyte Biology 2003, 74(2), 233-242.
  • Fraser KP, Gays F, Robinson JH, van Beneden K, Leclercq G, Vance RE, Raulet DH, Brooks CG. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. European Journal of Immunology 2002, 32(3), 868-878.
  • Gays F, Fraser KP, Toomey JA, Diamond AG, Millrain MM, Dyson PJ, Brooks CG. Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis. Journal of Immunology 2001, 166(3), 1601-1610.
  • Gays F, Unnikrishnan M, Shrestha S, Fraser KP, Brown AR, Tristram CMG, Chrzanowska-Lightowlers ZMA, Brooks CG. The mouse tumor cell lines EL4 and RMA display mosaic expression of NK- related and certain other surface molecules and appear to have a common origin. Journal of Immunology 2000, 164(10), 5094-5102.
  • Toomey JA, Salcedo M, Cotterill LA, Millrain MM, Chrzanowska-Lightowlers Z, Lawry J, Fraser K, Gays F, Robinson JH, Shrestha S, Dyson PJ, Brooks CG. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets. Journal of Immunology 1999, 163(6), 3176-3184.
  • Toomey JA, Shrestha S, de la Rue SA, Gays F, Robinson JH, Chrzanowska-Lightowlers ZMA, Brooks CG. MHC class I expression protects target cells from lysis by Ly49-deficient fetal NK cells. European Journal of Immunology 1998, 28(1), 47-56.

• Conference Proceedings (inc. Abstract)

  • Aust JG, Gays F, Buchanan E, Brooks CG. The expression and function of the NKRP1 receptor family in C-57 mice. In: Annual Congress of the British Society of Immunology. 2008, Glasgow: Wiley-Blackwell.

• Note

  • Mickiewicz KM, Kawai Y, Drage L, Gomes MC, Davison F, Pickard R, Hall J, Mostowy S, Aldridge PD, Errington J. Author Correction: Possible role of L-form switching in recurrent urinary tract infection (Nature Communications, (2019), 10, 1, (4379), 10.1038/s41467-019-12359-3). Nature Communications 2019, 10, 5254.